Clinical Trial

Dietary Modification In Inflammatory Bowel Disease Patients

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated May 31, 2025 (before its estimated September 10, 2025 completion). Its status may not reflect the trial's current state.
Summary
This research project aimed to develop a culturally appropriate Asian Inflammatory Bowel Disease Diet for the Malaysian population, based on the Crohn's disease exclusion diet (CDED). The study will be conducted in inflammatory bowel disease patients in University Malaya Medical Centre, which are ulcerative colitis and Crohn's disease patients. The objectives of this study are to assess the impact of diet in clinical outcome and gut microbiota changes in patients with inflammatory bowel disease (IBD). The study duration spans 24 weeks, during which comprehensive follow-ups will be conducted at 0, 6, 12, and 24 weeks, respectively. At each follow-up session, participants will be requested to provide stool and blood samples for meticulous assessment of clinical and biochemical responses.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-03-06.
Status change: Not Yet Recruiting → Recruiting 2025-05-27
Trial Details
NCT Number NCT06871267
Lead Sponsor University of Malaya
Conditions Crohn Disease
Enrollment 74 participants
Start Date 2025-03-01
Primary Completion 2025-09-10 (estimated)
Study Completion 2026-02-10 (estimated)
Updated on ClinicalTrials.gov 2025-05-31